Fatty acid-binding proteins sustain endothelial glycolysis and arterial programming in pulmonary arterial hypertension
Fatty acid-binding proteins sustain endothelial glycolysis and arterial programming in pulmonary arterial hypertension
批准号:
10657101
负责人:
Zhiyu Dai
金额:
$57.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-04-15 至 2027-03-31
关键词:
Animal ModelBlood VesselsCessation of lifeEndotheliumFailureFunctional disorderGlycolysisHeart HypertrophyLesionLinkMolecularPathogenesisPatientsPulmonary Vascular ResistanceReportingRoleSOX17 geneSignal TransductionTransgenic AnimalsVascular remodelingeffective therapyfatty acid metabolismfatty acid-binding proteinsnovelnovel therapeutic interventionprematurepulmonary arterial hypertensionpulmonary vascular remodeling
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Title: Fatty acid-binding proteins sustain endothelial glycolysis and arterial programming in
pulmonary arterial hypertension
Project Summary
Pulmonary arterial hypertension (PAH) is characterized by a progressive increase of pulmonary
vascular resistance and obliterative pulmonary vascular remodeling that result in right heart hypertrophy,
failure, and premature death. The underlying mechanisms of vascular remodeling and obliterative
vascular lesion formation remain unclear. Fatty acid metabolism dysfunction is linked to PAH. However,
the mechanistic role of fatty acid metabolism in regulating pulmonary vascular remodeling in the
pathogenesis of PAH has not been reported. We hypothesize that endothelial fatty acid-binding proteins
4 and 5 (FABP4-5) regulate endothelial glycolysis and arterial programming through HIF-2a/SOX17
signaling which contributes to severe vascular remodeling in the pathogenesis of PAH. We will 1) define
the novel role of endothelial FABP4-5 in the pathogenesis of PAH using multiple transgenic animal
models. 2) delineate the cellular and molecular mechanisms that FABP4-5 induces arterial programming
and pathogenesis of PAH. Completing our proposed study will provide a novel therapeutic strategy for
the effective treatment of PAH in patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
General Capillary to Arterial Endothelial Cell Transition in Pulmonary Arterial Hypertension
-
批准号:10716738
-
项目类别:
-
资助金额:$72.17万
-
财政年份:2023
-
负责人:Zhiyu Dai
-
依托单位:
Novel alveolar mechanisms of hypoxemia in hepatopulmonary syndrome
-
批准号:10718446
-
项目类别:
-
资助金额:$76.28万
-
财政年份:2023
-
负责人:Zhiyu Dai
-
依托单位:
Role of Endothelial SOX17 Deficiency in the Pathogenesis of Pulmonary Hypertension
-
批准号:10442975
-
项目类别:
-
资助金额:$47.98万
-
财政年份:2022
-
负责人:Zhiyu Dai
-
依托单位:
Role of Endothelial SOX17 Deficiency in the Pathogenesis of Pulmonary Hypertension
-
批准号:10594936
-
项目类别:
-
资助金额:$47.98万
-
财政年份:2022
-
负责人:Zhiyu Dai
-
依托单位:
Role of Smooth Muscle Progenitor Cells in Obliterative Vascular Remodeling and PH
-
批准号:10228636
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2019
-
负责人:Zhiyu Dai
-
依托单位:
Role of Smooth Muscle Progenitor Cells in Obliterative Vascular Remodeling and PH
-
批准号:10001625
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2019
-
负责人:Zhiyu Dai
-
依托单位:
Role of Smooth Muscle Progenitor Cells in Obliterative Vascular Remodeling and PH
-
批准号:9371373
-
项目类别:
-
资助金额:$13.26万
-
财政年份:2017
-
负责人:Zhiyu Dai
-
依托单位:
海外基金